Edition:
United States

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

20.89USD
4:00pm EDT
Change (% chg)

$-4.11 (-16.44%)
Prev Close
$25.00
Open
$24.04
Day's High
$24.05
Day's Low
$20.70
Volume
91,421
Avg. Vol
56,358
52-wk High
$50.50
52-wk Low
$3.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.61 -2.953
Sep '17 0.14 -1.611
Jun '17 0.19 -1.939
Mar '17 0.95 -2.804
FY 2016 Dec '16 1.07 -1.586
Sep '16 0.78 -2.655
Jun '16 1.68 -1.538
Mar '16 0.54 -2.333
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.91 33.50
P/E High - Last 5 Yrs. -- 289.20 46.07
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta -- 0.75 0.80
Price to Sales (TTM) 316.51 139.09 7.25
Price to Book (MRQ) -- 20.64 5.09
Price to Tangible Book (MRQ) -- 25.50 6.62
Price to Cash Flow (TTM) -- 130.26 25.50
% Owned Institutions 0.14 11.26 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.05 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -43.15 81.71 8.68
Sales (TTM) vs TTM 1 Yr. Ago -53.70 96.34 11.19
Sales - 5 Yr. Growth Rate -- 34.26 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -86.23 -64.57 22.73
EPS (TTM) vs TTM 1 Yr. Ago -14.76 -- --
EPS - 5 Yr. Growth Rate -- 48.47 10.28
Capital Spending - 5 Yr. Growth Rate -- 45.82 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.21 1.61 2.53
Current Ratio (MRQ) 0.25 6.04 3.61
LT Debt to Equity (MRQ) -- 23.33 11.39
Total Debt to Equity (MRQ) -- 25.72 14.02
Interest Coverage (TTM) -7.20 -190.60 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -3.45 35.01 54.05
Gross Margin - 5 Yr. Avg. -- 55.51 52.18
EBITD Margin (TTM) -347.24 -- --
EBITD - 5 Yr. Avg -- -150.51 15.90
Operating Margin (TTM) -416.15 -562.45 4.09
Operating Margin - 5 Yr. Avg. -- -162.33 11.23
Pre-Tax Margin (TTM) -421.09 -534.74 4.81
Pre-Tax Margin - 5 Yr. Avg. -- -168.92 11.54
Net Profit Margin (TTM) -421.09 -524.03 1.42
Net Profit Margin - 5 Yr. Avg. -- -168.92 7.87
Effective Tax Rate (TTM) -- -0.15 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.29 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,331,705 813,295,447
Net Income/Employee (TTM) -- 1,121,504 95,590,786
Receivable Turnover (TTM) 3.98 6.53 5.56
Inventory Turnover (TTM) 3.23 2.32 3.44
Asset Turnover (TTM) 0.53 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -221.96 -0.74 10.51
Return on Assets - 5 Yr. Avg. -- 0.80 11.54
Return on Investment (TTM) -3,077.67 -0.75 13.17
Return on Investment - 5 Yr. Avg. -- 4.16 14.94
Return on Equity (TTM) -3,425.63 -2.86 14.98
Return on Equity - 5 Yr. Avg. -- -0.19 16.23
  1 Year 3 Year 5 Year
Sales % -53.68 -45.04 --
EPS (TTM) % 16.74 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innovate Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.14%
# of Holders: 9
Total Shares Held: 32,273
3 Mo. Net Change: 4,403
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.